Skip to main content

Table 2 Subgroup analysis for the association between GHET1 expression and OS

From: Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis

Subgroups

No. of studies

No. of patients

Pooled HR (95% CI)

PHet

I2 (%)

P value

Cancer type

 Digestive system

6

663

1.751 [1.274, 2.408]

0.844

0.0

0.001

 Respiratory system

2

157

2.363 [1.515, 3.685]

0.656

0.0

< 0.001

 Others

4

294

2.377 [1.505, 3.754]

0.357

7.2

< 0.001

Cut-off value

 Median

10

867

2.067 [1.615, 2.646]

0.802

0.0

< 0.001

 Others

2

247

1.894 [1.096, 3.274]

0.185

43.0

0.022

Treatments

 Surgery

10

915

1.890 [1.475, 2.420]

0.899

0.0

< 0.001

 Others

2

199

2.918 [1.698, 5.015]

0.324

0.0

< 0.001

Sample size (n)

 ≤ 80

5

282

2.312 [1.574, 3.394]

0.725

0.0

< 0.001

 > 80

7

832

1.906 [1.444, 2.517]

0.609

0.0

< 0.001

NOS score

 ≤ 7

6

449

2.456 [1.602, 3.765]

0.524

0.0

< 0.001

 > 7

6

665

1.895 [1.454, 2.470]

0.850

0.0

< 0.001

  1. HR hazard ratio, CI confidence interval